$1M Bet On Glatfelter? Check Out These 4 Penny Stocks Insiders Are Buying

The Dow Jones closed lower by over 70 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Lexaria Bioscience

• The Trade: Lexaria Bioscience Corp LEXX Director Catherine C Turkel bought a total of 1,500 shares at an average price of $2.84. To acquire these shares, it cost around $4.27 thousand.
• What’s Happening: Lexaria Bioscience announced additional findings from its human clinical study HYPER-H21-4 demonstrating a potentially novel mechanism of action of its DehydraTECH-processed cannabidiol capsule formulation in reducing blood pressure.
• What Lexaria Bioscience Does: Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery.

Parks Glatfelter

• The Trade: Glatfelter Corp GLT SVP, IGSC and IT Wolfgang Laures acquired a total 277,000 shares at an average price of $3.72. The insider spent around $1.03 million to buy those shares.
• What’s Happening: Glatfelter posted weaker-than-expected quarterly results.
• What Glatfelter Does: Glatfelter Corporation manufactures and sells a variety of paper and fiber products. The company operates through two segments: Composite Fibers and Airlaid Materials.

Check This Out: Top 5 Health Care Stocks That May Rocket Higher In Q1 2023

PetVivo Holdings

• The Trade: PetVivo Holdings Inc PETV Director Joseph Jasper acquired a total of 2,600 shares at an average price of $2.98. To acquire these shares, it cost around $7.74 thousand.
• What’s Happening: PetVivo Holdings posted a Q3 loss of $0.23 per share.
• What PetVivo Holdings Does: PetVivo Holdings Inc is an emerging biomedical device company. The group is focused on the manufacturing, commercialization, and licensing of innovative medical devices and therapeutics for companion animals.

Don’t forget to check out our premarket coverage here

Vicarious Surgical

• The Trade: Vicarious Surgical Inc RBOT Director Philip Liang acquired a total of 37,500 shares at an average price of $2.86. The insider spent $107.14 thousand to buy those shares.
• What’s Happening: Vicarious Surgical reported a Q4 loss of $0.16 per share.
• What Vicarious Surgical Does: Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control.